COVID-19全国封锁对哮喘急性发作的影响:英国初级保健数据中断时间序列分析
该研究利用英国Optimum Patient Care数据库,对2020年1月至8月与2016-2019年同期及COVID-19前时期进行比较,采用中断时间序列分析。结果显示封锁后哮喘急性发作率显著下降,所有年龄组、性别和英格兰大部分地区均观察到下降。
要点
- 封锁后哮喘急性发作率显著降低,每100名哮喘患者每年减少近20次发作。
- 降幅在所有年龄组、性别及英格兰大部分地区一致。
- 仅无医院就诊/住院的发作类型在医疗设置分层中降幅显著。
核心结论
- COVID-19大流行期间哮喘急性发作的初级保健就诊显著减少。
研究设计与样本
- 基于Optimum Patient Care数据库的哮喘队列中断时间序列分析,以2020年3月23日封锁为中断点。
- 数据库共9 949 387名患者,其中100 165名哮喘患者在2016-2020年间至少经历一次急性发作。
- 共278 996次急性发作,其中49 938次(17.9%)需要医院就诊。
主要发现
- 封锁前后比较,所有患者急性发作率水平显著下降(-0.196次/人年;p<0.001;相当于每100名哮喘患者每年减少近20次发作)。
- 分层分析中,医疗设置层面降幅为0.005-0.244(仅无医院就诊/住院者显著),性别层面为0.210-0.277,年龄层面为0.159-0.367,地区层面为0.068-0.590。
关键数值与推荐
- 急性发作定义为哮喘相关医院就诊/住院(包括急诊就诊),或初级保健记录的急性口服糖皮质激素疗程且有呼吸科复查证据。
临床怎么用
- 临床医生应意识到疫情期间哮喘急性发作就诊减少,需关注患者是否因回避就医而延误治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of COVID-19 and ensuing national lockdown on asthma exacerbations is unclear. METHODS: We conducted an interrupted time-series (lockdown on 23 March 2020 as point of interruption) analysis in asthma cohort identified using a validated algorithm from a national-level primary care database, the Optimum Patient Care Database. We derived asthma exacerbation rates for every week and compared exacerbation rates in the period: January to August 2020 with a pre-COVID-19 period and January to August 2016-2019. Exacerbations were defined as asthma-related hospital attendance/admission (including accident and emergency visit), or an acute course of oral corticosteroids with evidence of respiratory review, as recorded in primary care. We used a generalised least squares modelling approach and stratified the analyses by age, sex, English region and healthcare setting. RESULTS: From a database of 9 949 387 patients, there were 100 165 patients with asthma who experienced at least one exacerbation during 2016-2020. Of 278 996 exacerbation episodes, 49 938 (17.9%) required hospital visit. Comparing pre-lockdown to post-lockdown period, we observed a statistically significant reduction in the level (-0.196 episodes per person-year; p<0.001; almost 20 episodes for every 100 patients with asthma per year) of exacerbation rates across all patients. The reductions in level in stratified analyses were: 0.005-0.244 (healthcare setting, only those without hospital attendance/admission were significant), 0.210-0.277 (sex), 0.159-0.367 (age), 0.068-0.590 (region). CONCLUSIONS: There has been a significant reduction in attendance to primary care for asthma exacerbations during the pandemic. This reduction was observed in all age groups, both sexes and across most regions in England.
引用
- Shah SA, Quint JK, Nwaru BI, et al. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021. PMID: 33782080. doi:10.1136/thoraxjnl-2020-216512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。